Issue 5/2022

Exploring novel systemic therapies for pancreatic cancer: a review of emerging anti-PD-1/PD-L1 combination therapy (995 — 1007)

He Zhang, Xiao-Rui Duan, Lu-Yang Xing, Yu-Xin Jia,  Jing-Yi Zhou,  Jian-Jun Ma

DOI: 10.4149/neo_2022_220306N246

CAR-T cells for the treatment of relapsed/refractory multiple myeloma in 2022: efficacy and toxicity (1008 — 1018)

 Martin Krejci, Zdenek Adam, Marta Krejci, Ludek Pour, Viera Sandecka, Martin Stork

DOI: 10.4149/neo_2022_220504N477

Circular RNAs: novel regulators of resistance to systemic treatments in breast cancer (1019 — 1028)

Xiao-Qiang Guo,  Yu-Ming Hua

DOI: 10.4149/neo_2022_220611N619

Sodium butyrate inhibits oral squamous cell carcinoma proliferation and invasion by regulating the HDAC1/HSPB7 axis (1029 — 1040)

Hai-Quan Yue, Peng-Fei Xu, Yi-Dan Guo, Jing Qi,  Rui-Min Liu,  De-He Li

DOI: 10.4149/neo_2022_220311N270

Exosomes from M2 macrophages promoted glycolysis in FaDu cells by inhibiting PDLIM2 expression to stabilize PFKL (1041 — 1053)

Peng Wang, Guang-Yao Li, Lei Zhou, Huai-Li Jiang, Yue Yang,  Hai-Tao Wu

DOI: 10.4149/neo_2022_220426N455

HSPA5 repressed ferroptosis to promote colorectal cancer development by maintaining GPX4 stability (1054 — 1069)

Ronglin Wang, Lei Hua, Peixiang Ma, Yang Song, Jie Min, Yongdong Guo, Cheng Yang,  Junqiang Li,  Haichuan Su

DOI: 10.4149/neo_2022_220331N363

BRAF inhibition promotes ER stress-mediated cell death in uveal melanoma (1070 — 1078)

Yinu Zhao, Yue Wang, Li Zhang, Weibin Wang, Thomas Fahey,  Ke Yao

DOI: 10.4149/neo_2022_220428N462

hsa_circ_0067514 suppresses gastric cancer progression and glycolysis via miR-654-3p/LATS2 axis (1079 — 1091)

Shao-Feng Jiang,  Rong-Rong Li

DOI: 10.4149/neo_2022_220225N209

Correlation between metastasis-associated gene 1 expression and tumor-associated macrophages in non-small cell lung cancer (1092 — 1100)

Ke Ma, Yan-Xin Li,  Qian-Qian Guo

DOI: 10.4149/neo_2022_220615N637

SPARC induces M2 polarization of macrophages to promote proliferation, migration, and angiogenesis of cholangiocarcinoma cells (1101 — 1107)

Shi-Kang Deng, Yun Jin, Yan Jin,  Jun-Feng Wang

DOI: 10.4149/neo_2022_220324N333

SPAG1 promotes the development of AML by activating the ERK/MAPK signaling pathway and affects the chemotherapy sensitivity of venetoclax (1108 — 1118)

Lu Liu, Jing Liu, Xiao-Jun Liu, Meng-Han Liu, Xue-Feng Feng,  Lin Yang,  Jian-Min Luo

DOI: 10.4149/neo_2022_220415N416

Anlotinib inhibits the proliferation and induces apoptosis by inactivating the AKT pathway in androgen receptor-negative prostate cancer cells (1119 — 1128)

Yan Xu, Ji Zheng,  Zhi-Ying Ye

DOI: 10.4149/neo_2022_220624N661

Resveratrol reduces lactate production and modifies the ovarian cancer immune microenvironment. (1129 — 1137)

Jing Chen, Shu-Ting Huang, Jian-Guo Chen, Jian-Hui He, Wu-Mei Lin, Zhi-Hong Huang,  Hai-Yan Ye,  Shan-Yang He

DOI: 10.4149/neo_2022_220414N410

lncRNA PSMB8-AS1 promotes colorectal cancer progression through sponging miR-1299 to upregulate ADAMTS5 (1138 — 1153)

Fang Zhao, Meng Wang, Yibin Zhang, Rujuan Su, Chenyang He, Xiao Gao, Ying Zan, Shuqun Zhang,  Yuguang Ma,  Chao Liu

DOI: 10.4149/neo_2022_220111N42

DDR1 promotes migration and invasion of breast cancer by modulating the Src-FAK signaling (1154 — 1164)

Qing Han, Fei Xiao, Lili Ma, Jinmei Zhou, Lan Wang, Huang Cheng, Jingjing Zhu, Fuli Yao,  Jianxin Lyu,  Linyong Du

DOI: 10.4149/neo_2022_220316N289

NBR2/miR-561-5p/DLC1 axis inhibited the development of multiple myeloma by activating the AMPK/mTOR pathway to repress glycolysis (1165 — 1174)

 Chang-Sheng Wang, Xiao-Bo Zhang, Xi-Tian Zhu, Rong-Sheng Chen

DOI: 10.4149/neo_2022_211102N1559

SNHG9/miR-214-5p/SOX4 feedback loop regulates osteosarcoma progression (1175 — 1184)

Chu-Jie Bai, Tian Gao, Jia-Yong Liu, Shu Li, Xin-Yun Wang,  Zheng-Fu Fan

DOI: 10.4149/neo_2022_220228N218

EFEMP2 increases the invasion ability of cervical cancer cells by promoting EMT via the Raf/MEK/ERK signaling pathway (1185 — 1197)

Na Li, Guo-Xin Ji,  Zi-Yan Yang

DOI: 10.4149/neo_2022_220117N74

Alternative splicing analysis showed the splicing factor polypyrimidine tract-binding protein 1 as a potential target in acute myeloid leukemia therapy (1198 — 1208)

Qiao-Xia Zhang, Yu-Ming Pan, Hong-Li Xiao, Na An, Si-Si Deng,  Xin Du

DOI: 10.4149/neo_2022_220314N279

Decreased expression of SVEP1 is closely related to a cancer stem cell-like phenotype and poor prognosis in hepatocellular carcinoma (1209 — 1216)

Wen-Chen Gong, Zhi-Qiang Han, Ming-Xi Guo, Shuai Zhao, Yu-Hong Guo,  Bin Meng,  Yan Sun,  Lu Chen

DOI: 10.4149/neo_2022_220614N629

XIST as a valuable biomarker for prognosis and clinical parameters in diverse tumors: a comprehensive meta- and bioinformatics analysis (1217 — 1227)

Mei-Jing Zhang, Zhe Yan, Jing Qin,  Tian-Hang Luo,  Biao Yang

DOI: 10.4149/neo_2022_220329N352

Association between BRAF expression in circulating tumor cells and the clinical feature of patients with multiple myeloma (1228 — 1236)

Ju-Xian Tang, Jia-Hui Zhang, Ke-Bing Zhou, Wang-Ting Li, Jin-Ying Wang, Qin Li,  Feng-Xia Yan,  Duan Xiao

DOI: 10.4149/neo_2022_220428N463

Predictive and prognostic impact of the different features of tumor budding in stage II colorectal cancer (1237 — 1245)

Yi-Tong Wang, Hong Wang, Hong-Wei Li, Bin Han,  Zhi-Ping Yang

DOI: 10.4149/neo_2022_220525N557

Preoperative circulating fibrinogen to albumin ratio in predicting 5-year prognosis of oral cancer radical surgery (1246 — 1252)

Hong Zhu, Wei Zhang, Pu Ye,  Meng Wu

DOI: 10.4149/neo_2022_220422N441